LegoChem Biosciences Inc (141080) — Capital Reinvestment Ratio
Latest as of December 2024:
0.07x
LegoChem Biosciences Inc (141080) has a Capital Reinvestment Ratio of 0.07x as of December 2024, meaning it reinvests 0% of its operating cash flow (₩78.48 Billion) in capital expenditures (₩5.70 Billion). See 141080 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.07x
Capex / Operating Cash Flow
Operating Cash Flow
₩78.48 Billion
KRW
Capital Expenditures
₩5.70 Billion
KRW
Data as of
Dec 2024
Most recent filing
LegoChem Biosciences Inc Capital Reinvestment Ratio (2019–2024)
This chart tracks LegoChem Biosciences Inc's Capital Reinvestment Ratio across 2 annual periods.
Annual Capital Reinvestment Ratio for LegoChem Biosciences Inc (2019–2024)
Year-by-year Capital Reinvestment Ratio for LegoChem Biosciences Inc from 2019 to 2024. For live market cap and broader valuation context, see LegoChem Biosciences Inc (141080) total market value.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.07x | ₩78.48 Billion | ₩5.70 Billion | ▼ -48.0% |
| 2019 | 0.14x | ₩24.11 Billion | ₩3.37 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow